T
Turn Therapeutics Inc D
D
TTRX
3.41000
USD
0.03
(0.89%)
Market Closed
Volume
1,128
EPS
-0
Div Yield
-
P/E
-28
Market Cap
101,577,216
Title: Turn Therapeutics Inc
Sector: Healthcare
Industry: Biotechnology
Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.